not held by our fund managers
Who’s trading Braveheart Bio (BRVE)?
None of the 22 fund managers we track own Braveheart Bio in their latest 13F filing. Here is what politicians and company insiders did.
Congress trades
0
0 members · recent disclosures
Congress buys / sells
0 / 0
Stock transactions
Insiders · Q3 2026
$159M
bought by 10 insiders
Insider sales
—
No open-market sales
Largest insider trades · Q3 2026All insider trades
| Insider | Type | Value | Price | Date |
|---|---|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner | Buy | $65M | $18.00 | 7 Aug 2026 |
| Erez Chimovits Director | Buy | $35M | $18.00 | 7 Aug 2026 |
| OrbiMed Genesis GP LLC Director | Buy | $35M | $18.00 | 7 Aug 2026 |
This is not a recommendation. Do your own research.
Coming soon · QWERTx Pro
Professionally managed portfolios, built around your life.
We are building QWERTx Pro: portfolios matched to your risk profile and time horizon, managed by experienced financial advisors. Join the waitlist to hear first when it launches.
